NO920852L - Midler for diagnostisering av demyelinisante neuropatier,saerlig multippel sklerose - Google Patents

Midler for diagnostisering av demyelinisante neuropatier,saerlig multippel sklerose

Info

Publication number
NO920852L
NO920852L NO92920852A NO920852A NO920852L NO 920852 L NO920852 L NO 920852L NO 92920852 A NO92920852 A NO 92920852A NO 920852 A NO920852 A NO 920852A NO 920852 L NO920852 L NO 920852L
Authority
NO
Norway
Prior art keywords
multiple sclerosis
neuropatias
diagnostizing
demyelinisant
measures
Prior art date
Application number
NO92920852A
Other languages
English (en)
Other versions
NO920852D0 (no
Inventor
Jean-Pierre Zanetta
Jean-Marie Warter
Sabine Kuechler
Guy Vincendon
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of NO920852L publication Critical patent/NO920852L/no
Publication of NO920852D0 publication Critical patent/NO920852D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/828—Protein A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Air Bags (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Valve Device For Special Equipments (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Steering-Linkage Mechanisms And Four-Wheel Steering (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fuses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Ignition Installations For Internal Combustion Engines (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

Anvendelse for diagnose av demyelinisante neuropatier og spesielt multippel sklerose eller SEP av endogene lectiner med en affinitet for mannoserlke glucaner, eller deres proteiske subenheter, idet disse ligniner eller deres subenheter oppviser et immunologisk slektskap henholdsvis med oppløselige cerebelløse lectin (cerebellar soluble lectine, CSL) eller deres proteiske subenheter. 1 Diagnosesett for multippel sklerose og mere generelt demyelinisante neuropatier, omfattende: - minst et endogent lectin av CSL-typen eller en subenhet derav som definert ovenfor, og i - de oppløsningsmidler og andre midler som er nødvendige for inkuberlngs og/eller påvisnlngs- trinnet.
NO920852A 1989-09-06 1992-03-04 Midler for diagnostisering av demyelinisante neuropatier,saerlig multippel sklerose NO920852D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8911667A FR2651581B1 (fr) 1989-09-06 1989-09-06 Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques.
PCT/FR1990/000638 WO1991003737A1 (fr) 1989-09-06 1990-08-30 Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques

Publications (2)

Publication Number Publication Date
NO920852L true NO920852L (no) 1992-03-04
NO920852D0 NO920852D0 (no) 1992-03-04

Family

ID=9385190

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920852A NO920852D0 (no) 1989-09-06 1992-03-04 Midler for diagnostisering av demyelinisante neuropatier,saerlig multippel sklerose

Country Status (14)

Country Link
US (1) US5225352A (no)
EP (1) EP0416984B1 (no)
JP (1) JP3032290B2 (no)
AT (1) ATE90791T1 (no)
AU (1) AU648516B2 (no)
CA (1) CA2024731A1 (no)
DE (1) DE69001972T2 (no)
DK (1) DK0416984T3 (no)
ES (1) ES2057476T3 (no)
FI (1) FI921009A0 (no)
FR (1) FR2651581B1 (no)
IE (1) IE64042B1 (no)
NO (1) NO920852D0 (no)
WO (1) WO1991003737A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871996A (en) * 1994-02-04 1999-02-16 Bio Merieux Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis
FR2679034A1 (fr) * 1991-07-10 1993-01-15 Centre Nat Rech Scient Determination de la malignite des cellules de tumeurs humaines ou animales, au moyen de lectines endogenes.
FR2689520B1 (fr) 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
FR2689521B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture.
FR2716198B1 (fr) * 1994-02-15 1996-04-19 Bio Merieux Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
FR2737500B1 (fr) 1995-08-03 1997-08-29 Bio Merieux Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques
EP0942987B1 (en) * 1996-11-26 2009-08-19 Bio Merieux Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
JPH11143616A (ja) 1997-11-10 1999-05-28 Sega Enterp Ltd 文字通信装置
AU5339699A (en) * 1998-08-06 2000-02-28 Johns Hopkins University School Of Medicine, The Compounds for altering cell surface sialic acids and methods of use therefor
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
WO2002028328A1 (en) 2000-10-05 2002-04-11 Seacoast Technologies, Inc. Expandable device for thermal therapy
US7858602B2 (en) * 2000-10-16 2010-12-28 Rodriguez Victorio C Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells
CA2501873A1 (en) * 2002-10-11 2004-04-22 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis
US6947870B2 (en) * 2003-08-18 2005-09-20 Baker Hughes Incorporated Neural network model for electric submersible pump system
FI20155280L (fi) 2015-04-15 2016-10-16 Medicortex Finland Oy Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311686A (en) * 1979-04-30 1982-01-19 The Immunology Development Corporation Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
FR2618439B1 (fr) * 1987-07-21 1990-05-25 Strosberg Arthur Sequences d'amino-acides reproduisant au moins en partie la sequence des lectines animales et humaines, leurs procedes d'obtention, leurs applications diagnostiques et therapeutiques
CA1338878C (en) * 1988-04-14 1997-01-28 Glenn E. Nedwin 14-beta-gal mammalian lectins

Also Published As

Publication number Publication date
ES2057476T3 (es) 1994-10-16
DE69001972T2 (de) 1993-09-23
EP0416984B1 (fr) 1993-06-16
ATE90791T1 (de) 1993-07-15
AU6421490A (en) 1991-04-08
DK0416984T3 (da) 1993-08-16
CA2024731A1 (fr) 1991-03-07
WO1991003737A1 (fr) 1991-03-21
FR2651581A1 (fr) 1991-03-08
NO920852D0 (no) 1992-03-04
JP3032290B2 (ja) 2000-04-10
US5225352A (en) 1993-07-06
AU648516B2 (en) 1994-04-28
DE69001972D1 (de) 1993-07-22
FI921009A7 (fi) 1992-03-06
FR2651581B1 (fr) 1994-05-13
EP0416984A1 (fr) 1991-03-13
FI921009A0 (fi) 1992-03-06
JPH05500858A (ja) 1993-02-18
IE64042B1 (en) 1995-06-28
IE903190A1 (en) 1991-03-13

Similar Documents

Publication Publication Date Title
NO920852L (no) Midler for diagnostisering av demyelinisante neuropatier,saerlig multippel sklerose
BRPI9912227A (pt) método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
DK0756708T3 (da) Anvendelse af humant neutrophil-lipocalin (HNL) som en diagnostisk markør og anti-HNL-antistof-præparat
GB2329246A (en) Diagnostic compositions and devices utlizing same
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
DK0925073T3 (da) Staphylococcus aureus antigen
NO173429C (no) Anvendelse av ferromagnetiske partikler i kontrastmidler for NMR-avbildning
FI891078A0 (fi) Peptider och antikroppar, som inhiberar plateletadhesion.
FI895959A0 (fi) Komposition, diagnostisk bruksfoerpackning och foerfarande foer snabb detektering av antikroppar.
DK0419387T3 (da) Hidtil ukendte hydrofile derivater, terapeutisk og diagnostisk anvendelse, diagnostiske eller terapeutiske kit og immunologiske reagenser
ATE147410T1 (de) Igm-antikörper gegen protamin
Davis et al. Circulating immune complexes and the nephropathy of cystic fibrosis
DE69209063D1 (de) Vorprüfung von prostatakrebs durch serum prostatischen spezifischen antigen
SHULMAN et al. Multiple forms of prostatic acid phosphatase
Szondy et al. Serial measurement of circulating immune complexes in myocardial infarction.
EP0598903A4 (en) (1-m (8) 3) - g (b) -D-GLUCANE ANALYSIS AGENT.
EP0375439A3 (en) Geminal diphenyl derivatives and their use in immunoassays
KR950009257A (ko) 골다공증 진단제
KR910017189A (ko) 암의 혈청진단법 및 이에 사용되는 키트(kit)
BE900911A (fr) Procede de diagnostic d'infections.
SU1113918A1 (ru) Антигельминтное средство
ES2019573T3 (es) Inmunoensayo para la deteccion de alfa-haloacetamidas.
Updike The ReSULT: The revised shortened Utley Sentence Lipreading Test.
Wood et al. Anomalous tumour marker concentrations in renal transplant patients
Fritz et al. Colour development of immunogold-labelled antibodies for light microscopy